Call to Action in Alpha-1 Antitrypsin Deficiency: Expert Guidance for Improving Early Detection and Multidisciplinary Management

Deepen your understanding of alpha-1 antitrypsin deficiency and improve your practice in identifying patients who should be screened, understanding the current evidence on investigational therapies, and developing personalized treatment plans through expert-written ClinicalThought commentaries, a text module with accompanying slides, and a podcast.

Share

Program Content

Activities

AATD-related liver disease
Alpha-1 Antitrypsin Deficiency: Improving Early Detection and Management of Liver Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 29, 2025

Expires: April 28, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.